This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Transgene S.a.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: The Innovative Contributions of Jean Marc Balloul
Introduction
Jean Marc Balloul is a notable inventor based in Lingolsheim, France. He has made significant contributions to the field of gene therapy, particularly in the development of targeted viral therapies. His work focuses on creating innovative solutions for treating serious diseases, including cancer.
Latest Patents
One of Jean Marc Balloul's key patents is titled "Poxvirus with targeted infection specificity." This invention involves a poxviral particle that possesses a targeted infection specificity due to a heterologous ligand moiety on its surface. This ligand is capable of specifically recognizing and binding to an anti-ligand molecule found on the surface of target cells. The patent also describes a vector that includes a nucleotide sequence encoding a chimeric polypeptide, which consists of the heterologous ligand moiety and part of a natural poxviral surface polypeptide. Additionally, the invention encompasses compositions that include the poxviral particle or vector, along with their therapeutic and prophylactic applications. This innovation is particularly relevant for gene therapy, especially in the prevention and treatment of cancer in mammals.
Career Highlights
Jean Marc Balloul has been associated with Transgene S.A., a company that specializes in developing innovative immunotherapies for cancer and infectious diseases. His work at Transgene has allowed him to contribute to groundbreaking research and development in the field of biotechnology.
Collaborations
Throughout his career, Jean Marc Balloul has collaborated with esteemed colleagues, including Stephane Paul and Michel Geist. These collaborations have further enhanced the impact of his research and innovations in the field.
Conclusion
Jean Marc Balloul's contributions to the field of gene therapy and his innovative patent on targeted poxviral particles highlight his significant role as an inventor. His work continues to pave the way for advancements in therapeutic applications, particularly in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile